ABSTRACT
INTRODUCTION: Smoking has been associated with increased incidence, severity of cutaneous lupus, and lupus activity. We looked at the association of both smoking and ethnicity with the individual damage items from the SLICC/ACR Damage Index. METHODS: Poisson regression was used to model the total SLICC/ACR Damage Index score against ever smoking. Cox regression was used to assess the relationship between time to individual damage items and ever smoking. Furthermore, we compared SLICC/ACR Damage Index items among African-American and Caucasian ever smokers. RESULTS: The study included 2629 patients, 52.6% Caucasian and 39.3% African-American. The prevalence of ever smokers was 35.8%. There was no significant difference in total SLICC/ACR Damage Index score between ever smokers and never smokers after adjustment for ethnicity, gender, age at diagnosis, and years of education. Ever smokers had more atherosclerotic cardiovascular damage and skin damage compared to non-smokers. Caucasian SLE patients who ever smoked were more likely to have muscle atrophy and atherosclerosis compared to Caucasian non-smokers. African-American patients who ever smoked were more likely to have skin damage compared to African-American non-smokers. African-Americans who smoked were more likely to have many more damage items (cataract, renal damage, pulmonary hypertension, cardiomyopathy, deforming or erosive arthritis, avascular necrosis, skin damage, and diabetes) compared to Caucasians who smoked. CONCLUSION: Our analysis proved the major effect of smoking on cardiovascular and cutaneous damage. Surprisingly, cardiovascular damage items had higher hazard ratios in Caucasian smokers than non-smokers while skin damage items hazard ratios were higher in African-American smokers compared to non-smokers.Key Points⢠This study is the largest cohort study to date evaluating the effect of smoking on the cumulative SLICC/ACR Damage Index and its individual damage items.⢠It is the only study that examined the effect of smoking on individual items of the SLICC/ACR Damage Index in terms of Caucasians vs. African-American ethnicity.⢠Our analysis proved the major effect of smoking on cardiovascular and cutaneous damage. Compared to non-smokers, Caucasian smokers had higher risk of cardiovascular damage while African-American smokers had more skin damage.⢠African-Americans who smoked were more likely to have many more damage items (cataract, renal damage, pulmonary hypertension, cardiomyopathy, deforming or erosive arthritis, avascular necrosis, skin damage, and diabetes) compared to Caucasians who smoked.
Subject(s)
Arthritis/ethnology , Black or African American/statistics & numerical data , Cardiovascular Diseases/ethnology , Cigarette Smoking/epidemiology , Diabetes Mellitus/ethnology , Kidney Failure, Chronic/ethnology , Lupus Erythematosus, Systemic/ethnology , White People/statistics & numerical data , Adult , Alopecia/epidemiology , Alopecia/ethnology , Arthritis/epidemiology , Atherosclerosis/epidemiology , Atherosclerosis/ethnology , Cardiomyopathies/epidemiology , Cardiomyopathies/ethnology , Cardiovascular Diseases/epidemiology , Cataract/epidemiology , Cataract/ethnology , Cicatrix/epidemiology , Cicatrix/ethnology , Cohort Studies , Diabetes Mellitus/epidemiology , Ex-Smokers , Female , Humans , Hypertension, Pulmonary/epidemiology , Hypertension, Pulmonary/ethnology , Kidney Failure, Chronic/epidemiology , Longitudinal Studies , Lupus Erythematosus, Cutaneous/epidemiology , Lupus Erythematosus, Cutaneous/ethnology , Lupus Erythematosus, Systemic/epidemiology , Lupus Nephritis/epidemiology , Lupus Nephritis/ethnology , Male , Middle Aged , Muscular Atrophy/epidemiology , Muscular Atrophy/ethnology , Non-Smokers , Osteonecrosis/epidemiology , Osteonecrosis/ethnology , Proportional Hazards Models , Smokers , Time , United States/epidemiologyABSTRACT
BACKGROUND: Patient-reported outcomes (PROs) are gaining an important role in the assessment of quality of care. There are currently limited data on the effect of payer type on PROs in total joint arthroplasty (TJA). This study compared both disease-specific and general health PROs among patients stratified according to their payer type. METHODS: Our institutional joint registry was queried for patients who underwent primary, elective, and unilateral hip and knee arthroplasty. Patients were divided according to their insurance type at the time of surgery into 3 groups: Medicaid, Medicare, or commercial. The outcomes assessed were the net changes in PROs as well as absolute scores at 6 months and 1 year. Six of the most commonly used PROs were assessed: Short Form-12 physical and mental components, Western Ontario and McMaster Universities Osteoarthritis Index, Single Assessment Numerical Evaluation, University of Californian Los Angeles activity level rating, and Oxford Hip Score. Analysis of variance and covariance were used. RESULTS: We evaluated 756 procedures (273 Medicaid, 270 Medicare, and 213 commercial insurance). Medicaid patients had significantly lower mean baseline scores across all PROs compared to either Medicare or commercial insurance patients. Medicaid patients were also more likely to be smokers, live alone, have lower educational level, African-American, and have nonprimary osteoarthritis as the indication for TJA. At 1-year follow-up, the net mean outcome gains were comparable among the 3 payer types (P > .05), but Medicaid patients continued to score lower while Medicare and commercial insurance patients continued to score higher (P < .01). When adjusting for all baseline differences among Medicaid patients, the negative effects of payer type resolved except for Oxford Hip Score which remained lower in the Medicaid group (P = .006). CONCLUSION: When using PROs to assess the value of care, the preoperative to postoperative changes are a better indicator of surgical success than comparing absolute values, especially in Medicaid patients. While TJA imparts similar net improvements to patients of all payer types, Medicaid coverage is a predictor of lower absolute outcome scores at any given time as result of increased baseline health burden (eg, depression, tobacco smoking, and poor overall well-being). Arthroplasty surgeons should be aware of these factors when counseling patients and seek optimization when necessary. The findings should be taken into account by stakeholders when constructing value-based payment models. Further research is needed to better understand the barriers leading to higher prevalence of increased health disparities among Medicaid beneficiaries and how to effectively address them.
Subject(s)
Arthroplasty, Replacement, Hip/economics , Arthroplasty, Replacement, Knee/economics , Elective Surgical Procedures/economics , Osteoarthritis, Hip/surgery , Osteoarthritis, Knee/surgery , Osteonecrosis/surgery , Patient Reported Outcome Measures , Aged , Arthroplasty, Replacement, Hip/statistics & numerical data , Arthroplasty, Replacement, Knee/statistics & numerical data , Elective Surgical Procedures/statistics & numerical data , Ethnicity , Female , Health Status Disparities , Healthcare Disparities , Humans , Insurance, Health , Male , Medicaid/economics , Medicare/economics , Middle Aged , Osteoarthritis, Hip/ethnology , Osteoarthritis, Knee/ethnology , Osteonecrosis/ethnology , Postoperative Period , Private Sector , Quality of Health Care , Registries , Severity of Illness Index , Surveys and Questionnaires , United StatesABSTRACT
PURPOSE: Spontaneous osteonecrosis of the knee affects the medial femoral condyle in patients above 55 years of age. Many reports and studies are available from western countries. But there is a gross paucity of literature on spontaneous osteonecrosis of the knee (SPONK) in the Indian subcontinent, either it is under-reported or detected at a later stage. The aim of our study was to detect SPONK in Indian population and describe its characteristics, treatment, and outcome. MATERIAL AND METHOD: A prospective study was conducted over a period of three years. All patients above 18 years with knee pain at rest and medial condyle tenderness without joint laxity were evaluated with plain radiographs and MRI. Further tests were done if radiological signs of osteonecrosis were present. Various parameters were recoded like Visual Analog Scale (VAS), Knee Society Score (KSS), and MRI Osteoarthritis Knee Score. Conservative treatment consisted of a combination of NSAIDs and bisphosphonates. Decompression with bone grafting was done if there was no improvement or deterioration at three month follow-up. RESULTS: Ten patients were diagnosed with SPONK. The mean age was 50 years with male predominance (60%) with the involvement of medial femoral condyle (80%) or left knee (70%). Most cases were in Koshino stage 1. Mean VAS was 6.5 and mean KSS was 59. All clinical parameters showed improvement at one year. DISCUSSION: A study with a bigger sample size and longer follow-up is needed to fill the lacunae of literature on this topic from the Indian subcontinent. In spite of the limitations, we did observe that in our population, males were more commonly affected than females, which is contrary to most studies on the subject. Also, the disease had an early age of onset (50 years) in Indian population as compared to Western and East Asian populations. CONCLUSION: Combined therapy of NSAIDs and bisphosphonates shows excellent results over a period of one year. Joint-preserving surgeries are effective even in Koshino stage 3 SPONK.
Subject(s)
Knee Joint/pathology , Osteonecrosis/diagnosis , Adult , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Asian People , Bone Transplantation/adverse effects , Bone Transplantation/methods , Cohort Studies , Conservative Treatment/adverse effects , Conservative Treatment/methods , Decompression, Surgical/methods , Diphosphonates/therapeutic use , Female , Humans , India , Knee Joint/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Osteonecrosis/ethnology , Osteonecrosis/therapy , Prospective Studies , Severity of Illness Index , Treatment OutcomeABSTRACT
PURPOSE: This study compared the relative incidence of treatment-related toxicities and the event-free and overall survival between Hispanic and non-Hispanic children undergoing therapy for acute lymphoblastic leukemia (ALL) on Dana-Farber Cancer Institute ALL Consortium protocol 05-001. PATIENTS AND METHODS: Secondary analysis of prospectively collected data from a phase III multicenter study in children and adolescents of 1-18 years with previously untreated ALL. RESULTS: Between 2005 and 2011, 794 eligible patients enrolled on DFCI 05-001, 730 of whom were included in this analysis (19% [N = 150] Hispanic, 73% [N = 580] non-Hispanic). Hispanic patients were more likely to be ≥10 years of age (32% vs. 24%, P = 0.045) at diagnosis. Toxicity analyses revealed that Hispanic patients had significantly lower cumulative incidence of bone fracture (P < 0.001) and osteonecrosis (ON; P = 0.047). In multivariable risk regression, the risk of ON was significantly lower in Hispanic patients ≥10 years (HR 0.23; P = 0.006). Hispanic patients had significantly lower 5-year event-free survival (EFS) (79.4%; 95% CI: 71.6-85.2) and overall survival (OS) (89.2%; 95% CI: 82.7-93.4) than non-Hispanic patients (EFS: 87.5%; 95% CI: 84.5-90.0, P = 0.004; OS: 92.7%; 95% CI: 90.2-94.6, P = 0.006). Exploratory analyses revealed differences between Hispanic and non-Hispanic patients in the frequency of common variants in genes related to toxicity or ALL outcome. CONCLUSION: Hispanic children treated for ALL on DFCI 05-001 had fewer bone-related toxicities and inferior survival than non-Hispanic patients. While disease biology is one explanatory variable for outcome disparities, these findings suggest that biologic and non-biologic mechanisms affecting drug delivery and exposure in this population may be important contributing factors as well.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Hispanic or Latino , Osteonecrosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma , Adolescent , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Child , Child, Preschool , Disease-Free Survival , Female , Fractures, Bone/chemically induced , Fractures, Bone/ethnology , Fractures, Bone/mortality , Humans , Incidence , Infant , Male , Osteonecrosis/chemically induced , Osteonecrosis/ethnology , Osteonecrosis/mortality , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/ethnology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Survival RateABSTRACT
BACKGROUND: Recent clinical studies have suggested that systemic metal ion levels are significantly elevated at midterm follow-up in patients with ceramic-on-metal (COM) bearing. However, it is not clear whether there is a correlation between patient-related factors including the lifestyle and elevated levels of serum metal ions following COM total hip arthroplasty (THA). METHODS: Serum metal levels were measured in 201 patients (234 hips) including 121 COM patients (140 hips) and 80 non-COM patients (94 hips). The Harris Hip Score, University of California, Los Angeles activity scale score, and Western Ontario and McMaster Universities Osteoarthritis Index score were measured and radiographs were obtained for the analysis. RESULTS: Significantly higher levels of cobalt (Co) and chromium (Cr) were detected in the serum of the COM THA group (Co: 1.86 ± 4.0 µg/L; Cr: 1.81 ± 2.87 µg/L) than those of the non-COM THA group (Co: 0.27 ± 0.14 µg/L; Cr: 0.19 ± 0.25 µg/L; P < .001). The serum metal levels of patients who achieved the squatting position and the kneeling position were significantly higher than those of patients who could not squat (Co: P = .033; Cr: P = .074) and kneel (Co: P = .049; Cr: P = .031). The metal ion levels of the COM THA group correlated with the total range of motion (Co: P = .0293; Cr: P = .0399). CONCLUSION: Patients who underwent a 36-mm COM THA showed high serum metal levels although good clinical outcomes at the midterm follow-up. We found that COM THA patients who were capable of greater range of motion, squatting, and kneeling are at risk of metal ion-related problems.
Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Hip Prosthesis/adverse effects , Ions/blood , Metals/blood , Osteoarthritis/surgery , Osteonecrosis/surgery , Acetabulum/surgery , Adult , Aged , Asian People , Ceramics , Chromium/blood , Cobalt/blood , Female , Follow-Up Studies , Humans , Life Style , Male , Middle Aged , Osteoarthritis/ethnology , Osteonecrosis/ethnology , Posture , Prosthesis Design , Range of Motion, Articular , Severity of Illness Index , Young AdultABSTRACT
OBJECTIVE: The aim of this population-based study is to examine the adverse events (AE) associated with longitudinal systemic glucocorticoid (GC) use among an ethnic Chinese systemic lupus erythematosus (SLE) cohort. METHODS: Our study subjects were patients with newly diagnosed SLE aged 18 and older who received at least 1 prescription of systemic GC between 2001 and 2012 from Taiwan's National Health Insurance Research Database (NHIRD). The earliest prescription date of systemic GC for each subject was defined as the index date. For each subject, we calculated the average prednisolone-equivalent dose and the medication possession ratio (MPR) of GC use every 90 days for each patient after the index date. Patients with a diagnosis of AE (defined by the International Classification of Diseases-9-Clinical Modification diagnosis code) during the followup were also identified from the NHIRD. Generalized estimating equations adjusted for propensity score were applied to examine the association between longitudinal GC use and risks of prespecified AE (musculoskeletal, gastrointestinal, ophthalmologic, infectious, cardiovascular, neuropsychiatric, metabolic, and dermatologic diseases). RESULTS: We identified 11,288 patients with SLE (mean followup: 6.28 yrs). Higher doses and higher MPR of GC were associated with increased risk of osteonecrosis [adjusted OR (aOR) 2.87-9.09]. Similar results were found regarding the risk of osteoporosis (aOR 1.71-3.67), bacterial infection (aOR 2.12-3.89), Cushingoid syndrome (aOR 6.51-62.03), and sleep disorder (aOR 1.42-3.59). CONCLUSION: To our knowledge, this is the first study to show that the dose and intensity of longitudinal use of GC were both associated with risk of AE among a nationwide Asian SLE cohort.
Subject(s)
Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/ethnology , Adult , Bacterial Infections/ethnology , Bacterial Infections/etiology , Cushing Syndrome/ethnology , Cushing Syndrome/etiology , Databases, Factual , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Glucocorticoids/administration & dosage , Humans , Longitudinal Studies , Male , Middle Aged , Multivariate Analysis , National Health Programs , Osteonecrosis/ethnology , Osteonecrosis/etiology , Osteoporosis/ethnology , Osteoporosis/etiology , Severity of Illness Index , Sleep Wake Disorders/ethnology , Sleep Wake Disorders/etiology , Taiwan/ethnology , Treatment Outcome , Young AdultABSTRACT
PURPOSE: In Kienböck's disease, the wrist displays certain characteristic radiological parameters, which have been reported to differ among countries. In the present study, we aimed to identify specific radiological parameters of the unaffected wrists in patients with unilateral Kienböck's disease and to determine the extent of the association of each parameter with the disease in Korea. METHODS: This retrospective case-control study assessed the radiological parameters of patients with Kienböck's disease ( n = 53) and controls ( n = 53), who visited our institution between January 2000 and May 2013. Ulnar variance (UV), radial inclination, lunate fossa inclination, lunate diameter, lunate height, lunate tilting angle (LTA), lunate covering index (LCI), and Ståhl index (SI) were measured and analyzed using a binary logistic regression model. RESULTS: We observed that wrists with a high LTA and LCI, and low UV and SI had a tendency to develop Kienböck's disease. CONCLUSION: In the Korean population, a high LTA and LCI, and low UV and SI of the unaffected wrists on plain radiography might be associated with Kienböck's disease. The radiographic characteristics of the unaffected wrists can differ between patients with unilateral Kienböck's disease and normal individuals.
Subject(s)
Asian People , Lunate Bone/diagnostic imaging , Osteonecrosis/diagnostic imaging , Osteonecrosis/ethnology , Wrist Joint/diagnostic imaging , Adolescent , Adult , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged , Radiography , Republic of Korea , Retrospective Studies , Young AdultABSTRACT
BACKGROUND: Steroid usage has been considered as a leading cause of non-traumatic osteonecrosis of the femoral head (ONFH), which is involved in hypo-fibrinolysis and blood supply interruption. Genetic polymorphisms in plasminogen activator inhibitor-1 (PAI-1) have been demonstrated to be associated with ONFH risk in several populations. However, this relationship has not been established in Chinese population. The aim of this study was to investigate the association of PAI-1 gene polymorphisms with steroid-induced ONFH in a large cohort of Chinese population. METHODS: A case-control study was conducted, which included 94 and 106 unrelated patients after steroid administration recruited from 14 provinces in China, respectively. Two SNPs (rs11178 and rs2227631) within PAI-1 were genotyped using Sequenom MassARRAY system. RESULTS: rs2227631 SNP was significantly associated with steroid-induced ONFH group in codominant (P = 0.04) and recessive (P = 0.02) models. However, there were no differences found in genotype frequencies of rs11178 SNP between controls and patients with steroid-induced ONFH (all P > 0.05). CONCLUSIONS: Our data offer the convincing evidence for the first time that rs2227631 SNP of PAI-1 may be associated with the risk of steroid-induced ONFH, suggesting that the genetic variations of this gene may play an important role in the disease development. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1569909986109783.
Subject(s)
Asian People/genetics , Femur Head Necrosis/genetics , Genetic Predisposition to Disease/genetics , Osteonecrosis/genetics , Plasminogen Activator Inhibitor 1/genetics , Polymorphism, Single Nucleotide/genetics , Steroids/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , China , Cohort Studies , Female , Femur Head Necrosis/epidemiology , Femur Head Necrosis/ethnology , Gene Frequency/genetics , Genetic Predisposition to Disease/ethnology , Genotype , Humans , Male , Middle Aged , Osteonecrosis/epidemiology , Osteonecrosis/ethnology , Risk Factors , Young AdultABSTRACT
Introdução: Os bifosfonatos são análogos dos pirofosfatos endógenos e possuem alta afinidade pelos tecidos mineralizados, atuando em sítios de grande formação e reabsorção óssea, sendo utilizados no tratamento da osteoporose, osteogênese imperfeita, displasia fibrosa, doença de Paget, mieloma múltiplo e nas metástases ósseas das complicações de vários tipos de neoplasias malignas. Contudo, numerosas complicações de seu uso vêm sendo descritas, destacando-se o aparecimento de osteonecrose nos ossos gnáticos.Objetivo: Alertar o cirurgião-dentista sobre os possíveis efeitos colaterais dessa classe de drogas sobre o tecido ósseo, os quais podem se assemelhar à outras patologias, como a osteorradionecrose e osteomielites. Verificou-se que a osteonecrose por bifosfonatos é mais comum em pacientes com mieloma múltiplo e câncer de mama, embora também tenha sido relatada em pacientes sob tratamento para osteoporose. Com relação à etiologia, sugere-se uma relação com exodontias e alterações periodontais, embora casos aparentemente espontâneos tenham sido relatados. A despeito da severidade da patologia, não existem protocolos bem estabelecidos de tratamento, variando de conservadores, utilizando a antibioticoterapia e bochechos com clorexidina 0,12%, à radicais, como a mandibulectomia e maxilectomia. Tratamentos alternativos também podem ser realizados, utilizando-se o plasma rico em plaquetas associado às ressecções. Diante dos efeitos dos bifosfonatos aos ossos gnáticos, deve-se dar enfâse à prevenção realizando exames clínicos e radiográficos, a fim de detectar possíveis infecções dentais e realizar os procedimentos convenientes como extrações dentárias, tratamentos endodônticos e periodontais, além de remoção de torus mandibulares ou maxilares, uma das áreas anatômicas mais acometidas.Conclusão: A instituição de protocolos prévios odontológicos a terapia dos bifosfonatos deveria ser uma rotina no início do tratamento médico, promovendo assim à prevenção da osteonecrose.